DOMAIN PARTERS VII L P [Rocket]

Date Filed	Type	Description
06/21/2021	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/15/2021	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/23/2020	SC 13D/A	DOMAIN PARTERS VII L P reports a 12.6% stake in Obalon Therapeutics, Inc.
08/08/2019	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/11/2019	SC 13G/A	DOMAIN PARTERS VII L P reports a 2% stake in Evofem Biosciences, Inc.
08/31/2018	SC 13D	DOMAIN PARTERS VII L P reports a 24.3% stake in Obalon Therapeuticss, Inc.
01/29/2018	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/08/2017	SC 13D/A	DOMAIN PARTERS VII L P reports a 7.5% stake in Esperion Therapeutics, Inc.
01/09/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
01/09/2017	SC 13G	OBALON THERAPEUTICS INC reports a 23.9% stake in Obalon Therapeutics, Inc.
01/13/2012	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
11/21/2011	SC 13D	Form SC 13D - General statement of acquisition of beneficial ownership
10/03/2011	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
12/09/2010	SC 13D	Form SC 13D - General statement of acquisition of beneficial ownership
12/03/2009	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
08/20/2009	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
07/30/2009	SC 13D	DOMAIN PARTERS VII L P reports a 7.7% stake in Orexigen Therapeutics, Inc.